These studies are not designed, documented, or archived according to FDA clinical research standards
A pilot human safety study with n=2 is far too small to support broad safety claims, and regulatory sources flag concerns about unapproved use, dose uncertainty, impurities, and lack of established therapeutic dosing [10][1516]
Cardio workouts like walking or cycling support cardiovascular health, while strength training helps preserve muscle mass and boosts metabolism
On 11 June 2026 the MHRA approved oral semaglutide, marketed as the Wegovy pill , the first oral GLP-1 receptor agonist licensed in the UK for weight loss
I'm down over 27 pounds and would recommend to anyone interested in tracking their macros while on GLP-1's. This app has been extremely helpful for tracking my calories and my weekly injections
sanahealth.in Follow Sana Health AI for insights on clinical reasoning, healthcare innovation, and the future of AI-assisted medicine